https://www.selleckchem.com/products/ly333531.html
Studies reporting on health service use provided evidence that rural/remote residence adversely impacts diagnostic time, ongoing follow-up, access to RA-care related practitioners and services, and variation in medication access and use, with prominent heterogeneity noted between countries. RA epidemiology and clinical outcomes are not necessarily different between rural/remote and urban populations within countries. Rural/remote patients face greater barriers to care which increases the risk for inequities in outcomes. RA epidemiology
Like
Comment
Share
